TMCnet News

Global Renal Dialysis Equipment MediPoint Report 2016-2022: Market Set to Reach $18 Billion by 2022 as Technological Innovation Drives Growth - Research and Markets
[October 20, 2016]

Global Renal Dialysis Equipment MediPoint Report 2016-2022: Market Set to Reach $18 Billion by 2022 as Technological Innovation Drives Growth - Research and Markets


Research and Markets has announced the addition of the "MediPoint: Renal Dialysis Equipment - Global Analysis and Market Forecasts" report to their offering.

Global Renal Dialysis Equipment Market Set to Reach $18 Billion by 2022 as Technological Innovation Drives Growth.

The global renal dialysis equipment market will rise steadily from $14.44 billion in 2015 to over $18 billion by 2022, representing a Compound Annual Growth Rate (CAGR) of 3.48%.

Growth will occur across the 10 major markets of the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China, and India, will primarily be driven by aging populations, growing awareness of therapeutic modalities, expanding demand in emerging countries, and technological innovation within the sector.

Strong demand for innovative products and therapies is one of the main growth factors in the renal dialysis market, as new technology improves outcomes of dialysis treatent. Most notably, peritoneal dialysis will see robust growth over the forecast period, widening at a CAGR of 6.92%.



Although hemodialysis has dominated the treatment space to date, the unique features of peritoneal dialysis mean it is gaining popularity. Firstly, it is less psychologically stressful than hemodialysis, as it does not use needles or require as much food and fluid restriction. Secondly, it gives patients more freedom, as it can be carried out at home and does not require the infrastructure of dialysis clinics.

Peritoneal dialysis will be particularly important in Asia-Pacific Markets, seeing a CAGR of almost 10%. This is in line with a general trend of emerging economies such as China, India, and Brazil demonstrating stronger growth than global averages due to large untreated disease populations starting to receive help.


Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Market Access

4 Unmet Needs

5 Competitive Assessment

6 Market Outlooks

7 Appendix

Companies Mentioned

  • Fresenius SE & Co. KGaA
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • Asahi Kasei Corporation
  • NxStage Medical, Inc.
  • Toray Medical Co., Ltd.
  • Medtronic plc

For more information about this report visit http://www.researchandmarkets.com/research/tkkp96/medipoint_renal


[ Back To TMCnet.com's Homepage ]